Vaxcyte, Inc. Ratios

Ratios Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Profitability
EBT Margin 46,273.33%133,902.50%1,276,342.86%1,476,185.71%-53,952.29%-14,126.01%10,504.05%
EBIT Margin 47,377.33%135,382.50%1,279,728.57%1,481,000.00%-55,965.30%-16,319.42%13,018.19%
EBITDA Margin 47,377.33%135,382.50%1,279,728.57%1,481,000.00%-55,965.30%-16,319.42%13,018.19%
Operating Margin 47,377.33%135,382.50%1,279,728.57%1,481,000.00%-55,965.30%-16,319.42%13,018.19%
Net Margin 39,313.33%125,685.00%1,274,528.57%1,429,671.43%-53,851.81%-14,026.01%10,504.05%
FCF Margin 42,986.67%120,850.00%682,614.29%1,827,828.57%-42,515.18%-10,908.37%10,858.38%
Leverage & Solvency
Interest Coverage Ratio -473.77-0.00B-0.00B-0.00B-0.00B
Times Interest Earned -473.77-0.00B-0.00B-0.00B-0.00B
Valuation
Enterprise Value 1.35B1.26B3.79B5.98B10.20B
Market Capitalization 1.35B1.26B3.79B5.98B10.20B
Return Ratios
Return on Sales 462.73%-539.52%-141.26%105.04%